Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Genetic testing for breast cancer predisposition.

M Gauthier-Villars1, S Gad, V Caux

  • 1Service de Génétique Oncologique, Institut Curie, Paris, France. dominique.lyonnet@curie.net

The Surgical Clinics of North America
|November 26, 1999
PubMed
Summary

Genetic testing for BRCA1 and BRCA2 mutations aids understanding of hereditary breast and ovarian cancers. Further research is needed for optimal management and to prevent genetic discrimination.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The impact of targeted therapies on molecular alterations identified by an institutional molecular tumor board: an approach based on ESCAT classification.

ESMO real world data and digital oncology·2026
Same author

[Genetic predisposition to breast cancer].

Annales de chirurgie plastique et esthetique·2025
Same author

Fluorescence tissue microscopy.

Progress in biophysics and molecular biology·2021
Same author

Tumor <i>BRCA</i> testing can reveal a high tumor mutational burden related to <i>POLE</i> pathogenic variants.

Gynecologic oncology reports·2021
Same author

Assessment of the functional impact of germline BRCA1/2 variants located in non-coding regions in families with breast and/or ovarian cancer predisposition.

Breast cancer research and treatment·2017
Same author

Comparing ataxias with oculomotor apraxia: a multimodal study of AOA1, AOA2 and AT focusing on video-oculography and alpha-fetoprotein.

Scientific reports·2017

Area of Science:

  • Genetics
  • Oncology
  • Medical Genetics

Background:

  • The identification of BRCA1 and BRCA2 genes has advanced the understanding of hereditary breast and ovarian cancer syndromes.
  • Germline mutations in BRCA1 and BRCA2 significantly increase susceptibility to these cancers in affected families.

Purpose of the Study:

  • To review current knowledge on BRCA1 and BRCA2 mutations in hereditary cancer.
  • To discuss management options for carriers of predisposing mutations.
  • To highlight the need for further research into risk modification and prevention of discrimination.

Main Methods:

  • Literature review of studies on BRCA1 and BRCA2.
  • Analysis of management strategies for mutation carriers.
  • Discussion of genetic testing implications.

Related Experiment Videos

Main Results:

  • BRCA1 and BRCA2 mutations are key factors in hereditary breast and ovarian cancers.
  • Management options include surveillance and prophylactic surgery.
  • Optimal management strategies require further elucidation.

Conclusions:

  • Continued research is essential to refine management protocols for BRCA1/2 mutation carriers.
  • Identifying risk-modifying factors is crucial for personalized cancer prevention.
  • Preventing discrimination against individuals at increased genetic risk is a societal imperative.